Skip to content
10-K

Annual Report

Jaguar Health, Inc. JAGX

0001193125-26-144470

← back to feed
Filed
Apr 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 2.33M sh
Shares Diluted FY 2025 · Dec 31, 2024 294.53K sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$23.69M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$29.38M
Cash And Equivalents FY 2025 · Dec 31, 2025 $968K
Cash And Equivalents FY 2025 · Dec 31, 2024 $8M
Current Liabilities FY 2025 · Dec 31, 2025 $40.65M
Current Liabilities FY 2025 · Dec 31, 2024 $19.7M
Total Liabilities FY 2025 · Dec 31, 2025 $57.01M
Total Liabilities FY 2025 · Dec 31, 2024 $44.45M
Current Assets FY 2025 · Dec 31, 2025 $20.35M
Current Assets FY 2025 · Dec 31, 2024 $32.2M
Total Assets FY 2025 · Dec 31, 2025 $38.32M
Total Assets FY 2025 · Dec 31, 2024 $53.43M
Eps Diluted FY 2025 · Dec 31, 2025 −$22.97
Eps Diluted FY 2025 · Dec 31, 2024 −$130.69
Eps Basic FY 2025 · Dec 31, 2025 −$22.97
Eps Basic FY 2025 · Dec 31, 2024 −$130.69
Sga Expense FY 2025 · Dec 31, 2025 $18.64M
Sga Expense FY 2025 · Dec 31, 2024 $16.33M
Rd Expense FY 2025 · Dec 31, 2025 $24.97M
Rd Expense FY 2025 · Dec 31, 2024 $16.54M
Net Income FY 2025 · Dec 31, 2025 −$53.58M
Operating Income FY 2025 · Dec 31, 2025 −$45.91M
Operating Income FY 2025 · Dec 31, 2024 −$30.83M
Cost Of Revenue FY 2025 · Dec 31, 2025 $3.77M
Cost Of Revenue FY 2025 · Dec 31, 2024 $1.96M
Capex FY 2025 · Dec 31, 2024 $16K